Craft

Gedeon Richter

Stock Price

$27.2

2024-10-29

Market Capitalization

$5.5 B

2024-10-29

Revenue

FT805.2 B

FY, 2023

Gedeon Richter Summary

Company Summary

Overview
Gedeon Richter is a pharmaceutical manufacturing, research, and development company. Its areas of expertise include original research, biotechnology, and women's healthcare. The company provides cardiovascular, central nervous system, and over-the-counter (OTC) products.
Type
Public
Status
Active
Founded
1901
HQ
Budapest, HU | view all locations
Website
https://www.gedeonrichter.com/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

Operating MetricsView all

Manufacturing Sites

8

Jul, 2023

Countries

50

Jul, 2023

Drugs Manufactured

200

Jul, 2023

LocationsView all

50 locations detected

  • Budapest HQ

    Hungary

    Gyömrői út 19-21

  • Parsippany-Troy Hills, NJ

    United States

    119 Cherry Hill Rd #325, Parsippany

  • Yerevan, Yerevan

    Armenia

    2 Zakyan St

  • Sydney, NSW

    Australia

    15 Blue St Suite 902

  • Wien, Wien

    Austria

    Hainburger Str. 20/17

  • Baku

    Azerbaijan

    29, 14 Istiglaliyyat St

and 44 others

Gedeon Richter Financials

Summary Financials

Revenue (Q2, 2024)
Ft216.3B
Gross profit (Q2, 2024)
Ft176.1B
Net income (Q2, 2024)
Ft70.3B
Cash (Q2, 2024)
Ft56.9B
EBIT (Q2, 2024)
Ft65.0B
Enterprise value
$4.3B

Footer menu